98 (PB086): First-in-human, phase 1 study of a selective RET inhibitor, LOXO-260, in patients with RET inhibitor refractory, RET-altered cancers

Saved in:
Bibliographic Details
Published in:European journal of cancer (1990) 2024-10, Vol.211, p.114622, Article 114622
Main Authors: Subbiah, V., Drilon, A., Bestvina, C., Garon, E.B., Wirth, L., Worden, F., Piha-Paul, S., Rotow, J., Johnson, M., Kang, H., Dong, S.M., Weiss, J., Pennell, N.A., Sukrithan, V., Lombard, A., Szpurka, A.M., Li, J., Manvelyan, M., Avsar, E., Brose, M.S.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0959-8049
DOI:10.1016/j.ejca.2024.114622